United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,329 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140,251 | 149,229 |
| Total Cites | 3,670 | 4,200 |
| H-index | 31 | 32 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 143 | 149 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1,209 | 1,361 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1,530 | 1,743 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,363 | 2,585 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.62 |
| Self-Citation Percentage |
12.62%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,390 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 143,433 | 149,382 |
| Total Cites | 3,491 | 4,013 |
| H-index | 29 | 30 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 124 | 130 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1,137 | 1,289 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1,437 | 1,650 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,230 | 2,446 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.64 |
| Self-Citation Percentage |
13.01%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,416 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145,110 | 147,765 |
| Total Cites | 3,244 | 3,763 |
| H-index | 28 | 30 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 102 | 108 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1,059 | 1,211 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1,338 | 1,551 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,055 | 2,268 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.66 |
| Self-Citation Percentage |
13.79%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,443 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145,164 | 146,599 |
| Total Cites | 3,113 | 3,626 |
| H-index | 27 | 29 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 96 | 102 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1,021 | 1,173 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1,286 | 1,499 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,962 | 2,174 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.67 |
| Self-Citation Percentage |
14.15%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.